Literature DB >> 29887655

A Bayesian approach to an interlaboratory comparison.

George S Jackson1, Paul Muzikar1, Brent Goehring2.   

Abstract

Interlaboratory comparisons are an important check of the quality of a measurement technique. In this paper we examine the accelerator mass spectrometry (AMS) measurement of 41Ca, an unstable isotope of calcium that has emerged as a valuable tracer for a variety of studies. We use a Bayesian framework to explore the quality and consistency of the AMS measurements made by Lawrence Livermore National Laboratory (LLNL) and the Purdue Rare Isotope Measurement Laboratory (PRIME Lab). This framework should be generalizable to other interlaboratory comparisons. The laboratories measured 47 samples, with each lab measuring an aliquot of each sample. The Bayesian approach allowed us to derive a probability distribution for four parameters reflecting the quality of the data, and to then address the following questions: (1) are the results from the two labs consistent? (2) are the uncertainties quoted by the two labs reasonable? We find that any consistent offset between the two labs is negligible, and that the uncertainties may be slightly underestimated.

Entities:  

Keywords:  Bayesian; accelerator mass spectrometry; interlaboratory comparison

Year:  2014        PMID: 29887655      PMCID: PMC5993439          DOI: 10.1016/j.chemolab.2014.12.006

Source DB:  PubMed          Journal:  Chemometr Intell Lab Syst        ISSN: 0169-7439            Impact factor:   3.491


  9 in total

Review 1.  Set-up and evaluation of interlaboratory studies.

Authors:  Yvan Vander Heyden; Johanna Smeyers-Verbeke
Journal:  J Chromatogr A       Date:  2007-02-22       Impact factor: 4.759

2.  Use of accelerator mass spectrometry for studies in nutrition.

Authors:  G S Jackson; C Weaver; D Elmore
Journal:  Nutr Res Rev       Date:  2001-12       Impact factor: 7.800

3.  Ultra-trace analysis of 41Ca in urine by accelerator mass spectrometry: an inter-laboratory comparison.

Authors:  George S Jackson; Darren J Hillegonds; Paul Muzikar; Brent Goehring
Journal:  Nucl Instrum Methods Phys Res B       Date:  2013-10-15       Impact factor: 1.377

4.  Development of 41Ca-based pharmacokinetic model for the study of bone remodelling in humans.

Authors:  Manju Sharma; Zeljko Bajzer; Susanta K Hui
Journal:  Clin Pharmacokinet       Date:  2011-03       Impact factor: 6.447

5.  Soy isoflavones do not affect bone resorption in postmenopausal women: a dose-response study using a novel approach with 41Ca.

Authors:  J M K Cheong; B R Martin; G S Jackson; D Elmore; G P McCabe; J R Nolan; S Barnes; M Peacock; C M Weaver
Journal:  J Clin Endocrinol Metab       Date:  2006-12-05       Impact factor: 5.958

6.  Labeling the human skeleton with 41Ca to assess changes in bone calcium metabolism.

Authors:  E Denk; D Hillegonds; J Vogel; A Synal; C Geppert; K Wendt; K Fattinger; C Hennessy; M Berglund; R F Hurrell; T Walczyk
Journal:  Anal Bioanal Chem       Date:  2006-10-11       Impact factor: 4.142

7.  Interpretation of 41Ca data using compartmental modeling in post-menopausal women.

Authors:  Wang-Hee Lee; Meryl E Wastney; George S Jackson; Berdine R Martin; Connie M Weaver
Journal:  Anal Bioanal Chem       Date:  2010-12-09       Impact factor: 4.142

8.  Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology.

Authors:  C M Weaver; B R Martin; G S Jackson; G P McCabe; J R Nolan; L D McCabe; S Barnes; S Reinwald; M E Boris; M Peacock
Journal:  J Clin Endocrinol Metab       Date:  2009-07-07       Impact factor: 5.958

9.  Bayesian Approach to Assessing Uncertainty and Calculating a Reference Value in Key Comparison Experiments.

Authors:  Blaza Toman
Journal:  J Res Natl Inst Stand Technol       Date:  2005-12-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.